(Q58868066)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Selective compensatory induction of hepatic HMG-CoA reductase in response to inhibition of cholesterol absorption (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Gene C Ness

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Reed C Holland

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

Experimental Biology and Medicine

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

559-565

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

Inhibitors of Cholesterol Biosynthesis Increase Hepatic Low-Density Lipoprotein Receptor Protein Degradation

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Efficacy and safety of coadministration of ezetimibe and statins in elderly patients with primary hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Ezetimibe/Simvastatin: a review of its use in the management of hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Autosomal recessive hypercholesterolaemia: normalization of plasma LDL cholesterol by ezetimibe in combination with statin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with p

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Low synthesis and high absorption of cholesterol characterize type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Cholesterol metabolism in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

FAMILIAL HYPERCHOLESTEROLAEMIA AND PRIMARY HYPOTHYROIDISM: COEXISTENCE OF BOTH DISORDERS IN A YOUNG WOMAN WITH SEVERE HYPERCHOLESTEROLAEMIA

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Regulation of hepatic lanosterol 14 alpha-demethylase gene expression by dietary cholesterol and cholesterol-lowering agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Ezetimibe normalizes metabolic defects in mice lacking ABCG5 and ABCG8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Diabetes alters the occupancy of the hepatic 3-hydroxy-3-methylglutaryl-CoA reductase promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Inhibitors Unmask Cryptic Regulatory Mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Dietary cholesterol regulates hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in rats primarily at the level of translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Degradation of HMG-CoA reductase in rat liver is cholesterol and ubiquitin independent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

A direct role for sterol regulatory element binding protein in activation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Schoenheimer effect explained--feedback regulation of cholesterol synthesis in mice mediated by Insig proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

ABCG5 and ABCG8 Are Obligate Heterodimers for Protein Trafficking and Biliary Cholesterol Excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Selective sterol accumulation in ABCG5/ABCG8-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Insulin resistance is associated with increased cholesterol synthesis and decreased cholesterol absorption in normoglycemic men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Caveolin-1 is not required for murine intestinal cholesterol transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

RETRACTED: Annexin 2-caveolin 1 complex is a target of ezetimibe and regulates intestinal cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

Multiple rare variants in NPC1L1 associated with reduced sterol absorption and plasma low-density lipoprotein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F153537020623100510

10.1177/153537020623100510

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16636304%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference